A daily newsletter summarizing recent activity & interesting startups globally
RECENT NOTABLE ACTIVITY – MEDICAL DEVICES
- Spirometrix, a developer of breath analysis devices for applications in disease diagnosis and management of asthma, raises $17.4M in a Series C round led by Shanghai Fosun Pharmaceutical. Link
- NightBalance, develops obstructive sleep apnea technology, raises €12.5M in a Series B round led by Inkef Capital and Gilde Healthcare Partners. Link
- Monteris, a developer of MRI-guided neurosurgical ablation tools, raises $10M in a Debt round led by Oxford Finance. Link
- NeuSpera Medical, develops miniaturized neurostimulation devices, raises an $8M in a Series A round. Link
- Nico Corporation, develops neurosurgery medical devices, raises $8M in a Debt round led by Square 1 Bank. Link
- Simavita, develops Urinary incontinence assessment tool, raises $7.3M in a Series B round. Link
- CryoTherapeutics, a developer of a proprietary cryotherapy system, raises €5.2M in a Series B round led by Creathor Venture. Link
- NeuroVision Imaging, a developer of digital imaging and diagnostic solutions for Alzheimer’s disease, raises $5M in a Series B round led by Wildcat Capital Management. Link
- Sofie Biosciences, develops molecular imaging instruments, raises $3.7M in a series B round. Link
- Arkis BioSciences, develops surgical instrumentation for shunt surgeries, raises $3.4M in a Series A round led by Innova Memphis. Link
- HeartWare, develops miniaturized ventricular assist devices, was acquired by Medtronic for $1.1B. Link
SOME INTERESTING STARTUPS FOUND
HydrUStent (2014, Braga) – Develops biodegradable, anti-bacterial urological stent.
LEADER BOARD – MEDICAL DEVICES
THERAPEUTICS
Cardiovascular
TriVascular (1998, Santa Rosa, IPO) – Medical devices for endovascular aortic repair. Went public in 2014.
CVRx (2001, Minneapolis, $297M) – Implantable technology for hypertension and heart failure. Backed by DaVita Healthcare Partners, Piper Jaffray, Ysios Capital, JJDC, InterWest Partners, Silicon Valley Bank, SightLine Partners, NEA, Kearny Venture Partners, Frazier Healthcare Partners, ABS Ventures.
Small Bone Innovations (2009, Morrisville, $171M) – Suite of orthopedic products for small bones and joints. Backed by Trevi Health Ventures, Goldman Sachs, Malaysian Life Sciences Capital Fund, NGN Capital, Viscogliosi Brothers, Axiom Ventures, Khazanah Nasional Berhad, 3i Group.
Auris Surgical Robots (2009, San Carlos, $184M) – Robotic microsurgical systems for ophthalmic surgery. Backed by NaviMed Capital, Lux Capital, Mithril Capital Management and Highland Capital Partners.
Medrobotics (2011, Raynham, $140M) – Robotic surgical devices for minimally invasive surgery. Backed by Hercules Technology Growth Capital and Pittsburgh Life Sciences Greenhouse.Ophthalmology
TearScience (2005,
Avedro (2007, Waltham, $130M) – Corneal cross-linking technology. Backed by Interwest, OrbiMed Advisors, Prism Venture Management, DeNovo Ventures, Flagship Ventures, Aperture Venture Partners, SCP Vitalife Partners, Borealis Ventures, Abingworth, Third Point, and Prism Venture.DIAGNOSTICSPlatform Technologies
Neusoft Medical System (1998, Shenyang, $410M) – Medical imaging device and software developer. Backed by China Everbright Group AG, Goldman Sachs, Hony Capital.
Butterfly Network (2011, Guilford, $100M) – Medical imaging devices
Impedimed (1999, Carlsbad, $106M) – Bioimpedance Spectroscopy technologies. Backed by Versant Venture Management, Starfish Ventures.
Veran Medical (2005, St.Louis, $83M) – Soft tissue navigation for diagnosis of lung cancer. Backed by Prolog Ventures, Versant Ventures, River Cities Capital Funds, Advantage Capital Partners, Rex Health Ventures, 3G Capital Partners and Vectis.Infectious Disease
Accelerate Diagnostics (2004, Tucson, IPO) – In vitro diagnostics to provide solutions for the antibiotic resistant infections. Went public in 2013.
Curetis (2007, Holzgerlingen, $85M) – Molecular diagnostics POC device for infectious diseases. Backed by Forbion, KfW Bankengruppe, HBM Partners, BioMedPartners, CD-Venture GmbH, Roche, Qiagen, Life Sciences Partners, Aeris Capital.MONITORING
Diabetes
OptiScan Biomedical (1994, Hayward, $156M) – Glucose monitoring systems for ICUs/CCUs. Backed by yet2Ventures, Mitsui, Medven, Lightstone Ventures, Oakwood Medical, Ascension Ventures, NGN Capital, Signet Healthcare Partners, Mitsui, Hercules Technology Growth Capital, Prism Venture, EGS Healthcare Capital Partners, Morgenthaler.
Senseonics (1996, Germantown, $124M) – Implantable system for continuous glucose monitoring. Backed by NEA, HealthCare Ventures, Rho Capital Partners, Anthem Capital Management, Delphi Ventures and Greenspring Associates.
Cardiovascular
CardioMEMS (2001, Atlanta, $153M, Acq.) – Wireless sensor-based implants for cardiac monitoring. Acquired by St. Jude Medical in 2014.
iRhythm Technologies (2006, SF, $95M) – Cardiac rhythm monitoring devices. Backed by Mohr Davidow Ventures, Synergy Life Science Partner, Novo A/S, Norwest Venture Partners, California HealthCare Foundation, Stanford University, Kaiser Permanente Ventures, New Leaf Venture Partners and New Leaf Ventures.
Vital Signs
EarlySense (2004, Ramat Gan, $85M) – Contact free patient monitoring solution. Backed by Noaber, Bridge Investment Fund, Samsung Venture Investment Corporation, Docor, ProSeed, Pitango VC, Israel, Mitsui & Co, JK&B Capital, Bank Hapoalim, Welch Allyn, Challenge.
Sotera Wireless (2004, San Diego, $68M) – In hospital patient monitoring device. Backed by Sanderling Ventures, Qualcomm Ventures, Intel Capital, EDB Investments, Safeguard, Delphi Ventures, Cerner Capital, West Health and Sanderling.
CLINICAL EQUIPMENT
TransMedics (1998, Andover, $252M) – Organ transplantation technology. Backed by Tudor Funds, Abrams Capital, Flagship Ventures, Kleiner Perkins, Foundation Capital, Sagamore, Hercules Technology Growth Capital, Alta Partners, Sherbrooke Capital, VantagePoint Capital Partners and i Group plc.
Caesarea Medical Electronics (
SUPPORT SYSTEMS
Ekso Bionics (2005, Richmond, IPO) – Bionic exoskeleton for people with paralysis. Went public in 2014.
BionX Medical (2007, Bedford, $75M) – Prosthetic device to aid movement of lower-limb amputees. Backed by Sigma Partners, General Catalyst, WFD Ventures and Gilde Healthcare.
MEDICATION MANAGEMENT
Proteus Digital Health (2001, Redwood City, $404M) – Medical adherence monitoring system. Backed by Asset Management Ventures, Medtronic, Carlyle, Fletcher Spaght, ON Semiconductor, SJM Telephony Svcs, Spring Ridge Ventures, ITOCHU International Inc., Adams Street Partners, Novartis, Oxford Finance Corporation, Essex Woodlands Health Ventures, Silicon Valley Bank, Oracle Corporation, Otsuka America Pharmaceutical and Kaiser Permanente Ventures.
For latest updates, visit the Medical Devices feed.